New data presented at ESMO 2020 have shown that immunotherapy is beneficial for patients with gastric and oesophageal cancers who currently have poor survival.
Sep 21, 2020
0
4
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, ...
Sep 20, 2020
0
9
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free ...
Sep 20, 2020
0
3
The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic kidney cancer. The late breaking results are presented at ESMO 2020.
Sep 19, 2020
0
7
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different ...
Sep 18, 2020
0
2
Delays and cancelation of cancer treatments and other safety measures undertaken to minimize the risk of exposure to the coronavirus (COVID-19) have generated a huge backlog in oncology care and research.Thethreat of delayed ...
Sep 14, 2020
0
9
Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being launched today [25 August] by the European Society for Medical Oncology (ESMO), the leading professional organisation ...
Aug 25, 2020
0
1
An ESMO interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published today in Annals of Oncology, encouraging medical oncologists worldwide not to discontinue or ...
Jul 31, 2020
0
1
Artificial intelligence (AI) holds promise for enabling earlier detection of pancreatic cancer, which is crucial to saving lives. The potential of AI is showcased in a study to be presented at the ESMO World Congress on Gastrointestinal ...
Jul 2, 2020
0
103
Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory ...
May 22, 2020
0
3
